Wenjie Dai
-
- MicroRNA in disease regulation 3
- Biomaterials top 10%
- Reproductive Medicine top 10%
-
- Soil and Unsaturated Flow 7
-
- Ferroptosis and cancer prognosis 7
-
- Thyroid Cancer Diagnosis and Treatment 4
-
- Thyroid and Parathyroid Surgery 4
-
- Groundwater flow and contamination studies 3
-
- Reproductive Biology and Fertility 3
-
- Peptidase Inhibition and Analysis 3
- Journals
- Nature Communications (2 papers)SHILAP Revista de lepidopterología (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wenjie Dai
64 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 152
- Biomaterials 103
- Immunology 152
- Molecular Biology 481
- Reproductive Medicine 59
Countries citing papers authored by Wenjie Dai
This map shows the geographic impact of Wenjie Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjie Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjie Dai more than expected).
Fields of papers citing papers by Wenjie Dai
This network shows the impact of papers produced by Wenjie Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjie Dai. The network helps show where Wenjie Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjie Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 22 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 19 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 3 | |
| 12 | 2021 | 10 | |
| 13 | 2019 | 104 | |
| 14 | 2019 | 6 | |
| 15 | 2019 | 111 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 5 | |
| 18 | 2019 | 16 | |
| 19 | 2018 | 73 | |
| 20 | 2018 | 8 |
About Wenjie Dai
Wenjie Dai is a scholar working on Cancer Research, Biomaterials and Hepatology, having authored 73 papers that have together received 1.4k indexed citations. Recurring topics across this work include Soil and Unsaturated Flow (7 papers), Ferroptosis and cancer prognosis (7 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Thyroid and Parathyroid Surgery (4 papers), Groundwater flow and contamination studies (3 papers), Reproductive Biology and Fertility (3 papers), MicroRNA in disease regulation (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (152 citations), Biomaterials (103 citations) and Immunology (152 citations). Wenjie Dai has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Thomas Unger, Juraj Čulman, Xufeng Fu, Thomas Herdegen, Yansong Wang, Xiuying Pei, Xing Du, Hang Han, Bo Xu and Hongchi Jiang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.